COVID-19: Japan starts antibody cocktail therapy: 3000 medical institutions
-Chief Cabinet Secretary will notify you within 25 days-
Chief Cabinet Secretary Katsunobu Kato
It was revealed at a press conference on August 25th.
The policy is to allow the use of “antibody cocktail therapy” in outpatient clinics.
Used as a therapeutic agent for mild and moderate cases of new coronavirus infection.
“Antibody cocktail therapy”:
Antibody cocktail therapy was approved in Japan on July 19th.
Used for mild to moderate inpatients at risk of aggravation.
Used in outpatient clinics:
It is possible to secure an observation system after administration,
For medical institutions that meet certain requirements
Make it usable in outpatient clinics.
Use at medical institutions:
About 3,000 medical institutions nationwide want to use it.
As of August 20:
It has already been administered to 5,600 people at 1,200 medical institutions.
“It has been pointed out that it is extremely effective from the field.”
We will work to ensure smooth administration.
Nihon Keizai Shimbun
https://www.nikkei.com/article/DGXZQOUA253CG0V20C21A8000000/
New Corona: What is antibody cocktail therapy?
-Combined administration of 2 antibodies to suppress growth-
Chugai
In antibody cocktail therapy, two types of antibodies called “casilibimab” and “imdebimab” are infused once.
It is called a “cocktail” because it is a mixture of two antibodies.
Nihon Keizai Shimbun
https://www.nikkei.com/article/DGXZQOUC047LX0U1A800C2000000/